Van ECK Associates Corp Sells 3,382 Shares of Danaher Corporation $DHR

Van ECK Associates Corp lowered its holdings in shares of Danaher Corporation (NYSE:DHR) by 0.2% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 1,625,814 shares of the conglomerate’s stock after selling 3,382 shares during the period. Van ECK Associates Corp’s holdings in Danaher were worth $309,685,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. BlackRock Inc. acquired a new stake in shares of Danaher in the second quarter valued at about $10,492,520,000. State Street Corp raised its holdings in Danaher by 1.7% during the 4th quarter. State Street Corp now owns 27,681,334 shares of the conglomerate’s stock worth $6,345,529,000 after purchasing an additional 472,608 shares during the last quarter. Capital International Investors boosted its stake in shares of Danaher by 8.9% in the 4th quarter. Capital International Investors now owns 18,246,008 shares of the conglomerate’s stock valued at $4,177,386,000 after purchasing an additional 1,487,768 shares during the last quarter. Wellington Management Group LLP increased its position in shares of Danaher by 10.4% during the second quarter. Wellington Management Group LLP now owns 16,316,834 shares of the conglomerate’s stock worth $3,108,031,000 after buying an additional 1,542,310 shares during the period. Finally, Price T Rowe Associates Inc. MD increased its position in shares of Danaher by 9.1% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 15,973,240 shares of the conglomerate’s stock worth $3,656,595,000 after buying an additional 1,334,221 shares during the period. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Stock Performance

Shares of DHR stock opened at $216.41 on Friday. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. The firm has a fifty day simple moving average of $199.46 and a two-hundred day simple moving average of $192.52. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The firm has a market capitalization of $152.13 billion, a PE ratio of 38.44, a price-to-earnings-growth ratio of 2.69 and a beta of 0.78.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm had revenue of $6.26 billion during the quarter, compared to analysts’ expectations of $6.12 billion. During the same period last year, the company earned $0.77 earnings per share. The business’s revenue was up 5.5% on a year-over-year basis. Analysts forecast that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on DHR shares. Citigroup began coverage on shares of Danaher in a report on Tuesday, May 26th. They issued a “buy” rating and a $230.00 target price on the stock. Stifel Nicolaus decreased their target price on Danaher from $260.00 to $220.00 and set a “buy” rating for the company in a research note on Wednesday, July 22nd. Royal Bank Of Canada increased their price target on Danaher from $200.00 to $215.00 and gave the stock an “outperform” rating in a report on Wednesday, July 22nd. HSBC dropped their target price on shares of Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a research report on Wednesday, June 3rd. Finally, Guggenheim decreased their price target on shares of Danaher from $235.00 to $200.00 and set a “buy” rating for the company in a research note on Wednesday, July 22nd. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $228.91.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.